Add like
Add dislike
Add to saved papers

Bacillus-derived consortium enhances Ginkgo biloba's health and resistance to Alternaria tenuissima.

BACKGROUND: Bacillus, as a plant-growth-promoting rhizobacteria, can enhance the resistance of plants to phytopathogens. So, in our study, the excellent biocontrol Bacillus strains were screened and used to control ginkgo leaf blight (Alternaria tenuissima).

RESULTS: Four biocontrol Bacillus strains-Bsa537, Bam337, Bso544, and Bsu503-were selected from 286 isolates based on their capacity to inhibit pathogens and promote plant growth. They significantly improved the resistance of ginkgo to leaf blight, especially the mixture of four Bacillus strains, which contributed to the decrease in lesion areas by more than 40%. Hence, a mixture of Bacillus strains was used to control ginkgo leaf blight in the field. Treatment efficiency varied from 30% to 100% (average 81.5%) and was higher than that of the control (from -2% to -18%, average - 8.5%), the antioxidant capacity of the treated ginkgo was also stronger. Additionally, ginkgo biomass rose as a result of treatment with the Bacillus mixture, including leaf weight, area, thickness, number of lateral roots, and root weight. Furthermore, the Bacillus mixture improved the ginkgo rhizosphere soil by boosting the number of beneficial microorganisms, lowering the number of pathogens, and quickening soil catabolism.

BACKGROUND: The Bacillus mixture improved the health status of ginkgo by protecting it from pathogen attack, promoting its growth, improving microorganism community in rhizosphere. This work closes a technological gap in biological control of ginkgo leaf blight, investigates the application methods of compound Bacillus biofertilizers, and establishes a framework for the population and commercialization of these products. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app